Prevalence of overweight and obesity and its relationship with chemical pregnancy in infertile women after assistant reproductive therapy
Amir
Almasi Hashiani
Ph.D Student, Department of Epidemiology and Reproductive Health, Reproductive Epidemiology Research Center, ACECR, Royan Institute, Tehran, Iran.
author
Mahdi
Sepidarkish
Ph.D Student, Department of Epidemiology and Reproductive Health, Reproductive Epidemiology Research Center, ACECR, Royan Institute, Tehran, Iran.
author
Reza
Omani Samani
Assistant Professor, Department of Epidemiology and Reproductive Health, Reproductive Epidemiology Research Center, ACECR, Royan Institute, Tehran, Iran.
author
text
article
2016
per
Introduction: Obesity and overweight is one of the most important health-related problems worldwide. Obesity can affect chemical pregnancy success rate after assistant reproductive therapy. This study was performed with aim to determine the association between body mass index (BMI) and chemical pregnancy after IVF or intracytoplasmic sperm injection for infertile women in Royan Institute. Methods: In this retrospective cohort study, 2983 infertile women who referred to Royan Institute from 2012 to 2014 were evaluated. The independent variable was body mass index and the outcome was the occurrence of chemical pregnancy in infertile women which were determined using β-HCG levels. Data analysis was performed using Stata software (version 13). PResults: The mean of BMI in infertile women was 26.7±4.31 kg/m2 and the prevalence of overweight and obesity in infertile women was 56.99%. The chance of non-success in chemical pregnancy in women with class II obesity was 2.69 times against women with normal BMI and the chance of non-success in chemical pregnancy in overweight women was 1.28 times against women with normal BMI. Conclusion: There is a significant relationship between body mass index and rate of chemical pregnancy and the chance of success in chemical pregnancy in overweight and obese women is less than women with normal BMI.
The Iranian Journal of Obstetrics, Gynecology and Infertility
Mashhad University of Medical Sciences
1680-2993
19
v.
22
no.
2016
1
7
https://ijogi.mums.ac.ir/article_7704_a4926f7e16e9bf907ccabe3c687265ae.pdf
dx.doi.org/10.22038/ijogi.2016.7704
Comparative effect of Flaxseed and Evening primrose oil with vitamin E on severity of Cyclic Mastalgia in women
Farzaneh
Jafarnezhad
Instructor of Department of Midwifery, School of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran.
author
Elham
Adib Moghaddam
MSc student of Midwifery, School of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran.
author
Seyyed
Ahmad Emami
Professor, Department of Pharmacognosy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
author
Azadeh
Saki
Assistant Professor, Department of Biostatistics and Epidemiology, School of Public Health, Mashhad University of Medical Sciences, Mashhad, Iran.
author
Maryam
Hami
Associate Professor, Department of Internal Surgery, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
author
Atieh
Mohammadzadeh Vatanchi
Assistant Professor, Department of Obstetrics and Gynecology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
author
text
article
2016
per
Introduction: Flaxseed, Evening Primrose Oil and Vitamin E are the first line treatment of Cyclic Mastalgia, but there is no evidence which reported that the impact of which one is more. So, this study was performed with aim to compare the effect of Flaxseed and Evening Primrose Oil with Vitamin E on the severity of Cyclic Mastalgia in women. Methods: This clinical trial study was performed on 90 patient with Cyclic Mastalgia referred to gynecology clinic of Mashhad Ghaem hospital or the students living in dormitories of Mashhad University of Medical Sciences in 2015. Patients were randomly divided in to three 30 cases groups including Flaxseed group (30 mg daily powder of Flaxseed), Evening Primrose Oil capsule (2 1000mg capsules, daily) and Vitamin E (1 capsule of 400 IU, daily) for two menstrual period. The severity of mastalgia was measured through … at the baseline and end of every two interventional period. Data was analyzed by SPSS software (version 16) and Chi-square, Fridman, Fisher Exact, and ANOVA. PResults: Median of the severity of mastalgia decreased in all three groups of Flaxseed, Evening Primrose Oil and Vitamin E after the intervention. But, three groups were not significantly different in the median of mastalgia before (P=0.779), one month (P=0.380) and two months after the intervention (P=0.764). Conclusion: Use of Flaxseed, Evening Primrose Oil or Vitamin E lead to reduction in the severity of mastalgia and this reduction in all three groups is the same.
The Iranian Journal of Obstetrics, Gynecology and Infertility
Mashhad University of Medical Sciences
1680-2993
19
v.
22
no.
2016
8
16
https://ijogi.mums.ac.ir/article_7705_b697f622731bf9b45e80e8072c59728a.pdf
dx.doi.org/10.22038/ijogi.2016.7705
Investigation of 1 to 10-year survival of breast cancer in Iranian women: a systematic review and meta-analysis
Arezoo
Karimi
M.Sc. in Epidemiology, Student Research Community, School of Public Health, Ilam University of Medical Sciences, Ilam, Iran.
author
Zeinab
Moradi
M.Sc. in Epidemiology, Student Research Community, School of Public Health, Ilam University of Medical Sciences, Ilam, Iran.
author
Kourosh
Sayehmiri
Associate Professor, Department of Biostatistics, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
author
Ali
Delpisheh
Professor, Department of Clinical Epidemiology, Social-Psychological Prevention Research Center, of Clinical Epidemiology, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
author
Fatemeh
Sayehmiri
M.Sc. in Biochemistry, Student Research Community, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran
author
text
article
2016
per
Introduction: Breast cancer is the most common malignancy in women which causes 19% of annual deaths of women in the world. Estimation of survival rate in patients with this cancer can be used as an important indicator of disease control and evaluation of the treatment methods. Breast cancer survival rates in the country have been reported sporadically and comprehensive information is not available. Therefore, this study was performed with aim to evaluate one to ten-years survival of breast cancer in women by meta-analysis. Methods: This is a Systematic Review and Meta-analysis study about one to ten-year survival of breast cancer in Iranian women. To do this, the databases including Medlib, Google Scholar, Pubmed, ISI, Science direct, SID, Medline, Magiran, and Irandoc were searched by two trained researchers independently and the articles through key terms and combinations were extracted up to 2013. Data was analyzed by a random effects model meta-analysis, Meta-regression and Cochran test using STATA software (version 11.1) and SPSS software (version 16). Results: A total of 17 studies with sample size of 11,909 samples were meta-analyzed. 1-year survival rate for breast cancer in Iranian women was 94%, 5-years, 71% and 10-years, 56% and also survival rates of 2, 3 and 4 years were 83%, 79%, 71%, respectively. Minimum and maximum 1-year survival rate was related to the study in Ardebil (82%) and the study in Tehran (99%), respectively. Discussion: 1 and 5-year survival rate of breast cancer in Iranian women is desirable and survival rate decreases with increasing years passed from the time of diagnosis.
The Iranian Journal of Obstetrics, Gynecology and Infertility
Mashhad University of Medical Sciences
1680-2993
19
v.
22
no.
2016
17
25
https://ijogi.mums.ac.ir/article_7706_5019bb4e2c84df2229024e0aba5f912b.pdf
dx.doi.org/10.22038/ijogi.2016.7706